Instrument Inactif

Autres langues INSTEM

Actions

INS

GB00B3TQCK30

Autres langues

20/04	Instem Limited Announces Termination of Director Appointment, Effective April 20, 2026
15/04	Instem Announces Appointment of Szczepan Baran as Chief Scientific Officer
19/03	Instem And U.S. Food And Drug Administration Extend Research Collaboration Agreement
02/12	Instem Unveils New Global Headquarters in Boston, Massachusetts
09/10/25	Instem Announces Enhanced Capabilities of Climb? Software for Non-GLP In Vivo Research
31/07/25	Instem Limited acquired Xybion Digital Inc. from Banerjee Group LLC and others.
28/07/25	Instem Limited acquired Rockstep Solutions, Inc.
17/07/25	Instem Announces Provantis 12: A Powerful Step Forward in Preclinical Study Management
19/06/25	Instem Limited Reports Earnings Results for the Full Year Ended December 31, 2024
19/05/25	Instem Limited acquired Strong Tower Solutions, Inc.
08/01/25	Instem Introduces Cloud-Hosted Non-Glp Pathology Module for Provantis
27/12/24	Instem plc acquired Trimetra Limited.
05/10/24	Instem Limited Reports Earnings Results for the Full Year Ended December 31, 2023
17/06/24	Instem and Proscia Partners to Accelerate Preclinical Development with Digital Pathology
25/01/24	Instem Enables Clients to Leverage ICH S1B Weight of Evidence Guideline
21/11/23	Instem Delists from London Bourse's AIM After Merger with ArchiMed
20/11/23	France's Archimed Completes Acquisition of UK's Instem
20/11/23	Instem plc Announces Board Resignations
20/11/23	ArchiMed SAS agreed completed the acquisition of Instem plc (AIM : INS) from group of sellers.
16/11/23	Instem acquisition by Ichor sanctioned by UK court
16/11/23	Instem : Issue of Equity, PDMR Dealings and Rule 2.9 Announcement
16/11/23	UK Court Clears Archimed’s Takeover of Instem
15/11/23	Samson Rock Capital LLP - Form 8.3 - Instem Plc
13/11/23	Samson Rock Capital LLP - Form 8.3 - Instem Plc
10/11/23	Samson Rock Capital LLP - Form 8.3 - Instem Plc